Aurinia Pharmaceuticals stock forecast
Aurinia Pharmaceuticals (IKAP) Stock Forecast & Price Target
IKAP Analyst Ratings
IKAP Stock 12 Month Forecast
Average Price Target
EUR 16.93▲(15.76% Upside)Detailed List of Analyst Forecasts
| Price Target | Article | |||||||
|---|---|---|---|---|---|---|---|---|
| David Martin PhD | Bloom Burton | EUR 18.71 | buy | 27.94%Upside | Reiterated | 11/02/26 | ||
| Douglas Miehm | RBC Capital | EUR 14.26→EUR 16.04 | hold | 9.67%Upside | Assigned | 10/30/26 | ||
| Stacy Ku | TD Cowen | EUR 15.15→EUR 16.04 | buy | 9.67%Upside | Assigned | 10/21/26 | ||
| Arthur He CFA | H.C. Wainwright | EUR 15.15 | buy | 3.57%Upside | Reiterated | 02/27/26 | ||
| Joseph Schwartz | Leerink Partners | EUR 14.26 | hold | -2.52%Downside | Downgraded | 12/03/25 |
| Rating | Article | ||||
|---|---|---|---|---|---|
| David Martin PhDBloom Burton | BuyReiteratedEUR 18.71 | 11/02/26 | 27.94%Upside | ||
| Douglas MiehmRBC Capital | HoldAssignedEUR 14.26→EUR 16.04 | 10/30/26 | 9.67%Upside | ||
| Stacy KuTD Cowen | BuyAssignedEUR 15.15→EUR 16.04 | 10/21/26 | 9.67%Upside | ||
| Arthur He CFAH.C. Wainwright | BuyReiteratedEUR 15.15 | 02/27/26 | 3.57%Upside | ||
| Joseph SchwartzLeerink Partners | HoldDowngradedEUR 14.26 | 12/03/25 | -2.52%Downside |
Best Analysts Covering Aurinia Pharmaceuticals
Copying Stacy Ku's trades and holding each position for 3 Months would result in 73.33% of your transactions generating a profit, with an average return of +10.19% per trade.
Copying Stacy Ku's trades and holding each position for 1 Year would result in 86.67% of your transactions generating a profit, with an average return of +38.71% per trade.
Copying Stacy Ku's trades and holding each position for 2 Years would result in 93.33% of your transactions generating a profit, with an average return of +60.19% per trade.
IKAP Analyst Recommendation Trends
| Rating | Jun 26 | Jul 26 | Aug 26 | Sep 26 | Oct 26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 |
| Buy | 3 | 5 | 5 | 4 | 2 |
| Hold | 2 | 2 | 2 | 3 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 5 | 7 | 7 | 7 | 3 |
In the current month, IKAP has received 2 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. IKAP average Analyst price target in the past 3 months is 16.93.
IKAP Financial Forecast
IKAP Earnings Forecast
Next quarter’s earnings estimate for IKAP is EUR 0.19 with a range of EUR 0.15 to EUR 0.21. The previous quarter’s EPS was EUR 0.20. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
IKAP Sales Forecast
Next quarter’s sales forecast for IKAP is EUR 75.74M with a range of EUR 74.02M to EUR 77.11M. The previous quarter’s sales results were EUR 74.46M. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.
